TIG Advisors’s Amryt Pharma AMYT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
– Sell
-1,666,821
Closed -$24.3M – 80
2023
Q1
$24.3M Buy
+1,666,821
New +$23.6M 1.78% 12

TIG Advisors's AMYT Position: Q2 2023 in Review

TIG Advisors sold out of Amryt Pharma (AMYT) in Q2 2023, closing a stake of 1,666,821 shares — an estimated $24.3M sold.

TIG Advisors first reported a position in AMYT in Q1 2023 and held it in 1 quarter. The position peaked at $24.3M in Q1 2023. 0 funds tracked by Wall St. Rank hold AMYT as of Q2 2023.

  • TIG Advisors reported no remaining Amryt Pharma position as of Q2 2023 after selling out during the quarter.
  • TIG Advisors sold 1,666,821 Amryt Pharma shares in Q2 2023, an estimated $24.3M.
  • TIG Advisors first reported a position in Amryt Pharma in Q1 2023 and held it in 1 quarter.
  • TIG Advisors's Amryt Pharma position peaked at $24.3M in Q1 2023.
  • 0 funds tracked by Wall St. Rank held Amryt Pharma as of Q2 2023.

Based on TIG Advisors's 13F filing for Q2 2023, filed 14 Aug 2023.